Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)

SHA:688799 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,362	1,399	1,403	1,273	1,135	926.86
Other Revenue	14.06	14.06	29.33	19.2	11.95	23.76
Revenue	1,376	1,413	1,433	1,293	1,147	950.63
Revenue Growth (YoY)	-4.98%	-1.39%	10.84%	12.74%	20.61%	15.28%
Cost of Revenue	538.09	547.62	512.15	421.91	319.33	262.39
Gross Profit	838.19	865.33	920.64	870.75	827.26	688.24
Selling, General & Admin	536.04	547.26	595.34	595.97	585.96	460.26
Research & Development	153.51	158.33	103.18	88.67	70.06	63.66
Other Operating Expenses	36.65	20.3	17.68	16.9	14.05	12.6
Operating Expenses	726.38	726.21	717.67	703.76	671.38	538.79
Operating Income	111.81	139.12	202.97	166.99	155.89	149.45
Interest Expense	-0.02	-0.02	-	-	-	-
Interest & Investment Income	19.42	16.84	16.02	15.21	5.87	0.86
Currency Exchange Gain (Loss)	0.42	0.42	0.01	0.53	-0.03	-0.28
Other Non Operating Income (Expenses)	-1.23	-1.1	-0.24	-0.24	-0.51	3.55
EBT Excluding Unusual Items	130.41	155.27	218.76	182.5	161.21	153.58
Gain (Loss) on Sale of Investments	-21.46	-24.31	-	-	-	-6.29
Gain (Loss) on Sale of Assets	-0.03	-0.03	-0.48	-0.89	-0.39	0.01
Asset Writedown	1.15	-	-	-	-	-
Legal Settlements	-	-	-5.28	-	-1.95	-
Other Unusual Items	30.73	30.75	16.87	13.36	21.16	17.19
Pretax Income	140.8	161.68	229.88	194.96	180.03	164.48
Income Tax Expense	17.43	22.92	36.84	21.57	19.27	19.45
Earnings From Continuing Operations	123.37	138.76	193.04	173.39	160.76	145.03
Minority Interest in Earnings	22.1	25.56	18.28	9.42	-	-
Net Income	145.48	164.32	211.32	182.8	160.76	145.03
Net Income to Common	145.48	164.32	211.32	182.8	160.76	145.03
Net Income Growth	-34.50%	-22.24%	15.60%	13.71%	10.85%	25.01%
Shares Outstanding (Basic)	94	94	94	94	80	70
Shares Outstanding (Diluted)	94	94	94	94	80	70
Shares Change (YoY)	-0.30%	-0.03%	0.18%	17.21%	13.60%	0.13%
EPS (Basic)	1.55	1.75	2.25	1.95	2.01	2.06
EPS (Diluted)	1.55	1.75	2.25	1.95	2.01	2.06
EPS Growth	-34.30%	-22.22%	15.38%	-2.99%	-2.43%	24.85%
Free Cash Flow	-167.29	-91.65	108.68	23.8	22.63	50.91
Free Cash Flow Per Share	-1.78	-0.98	1.16	0.25	0.28	0.72
Dividend Per Share	0.600	0.600	0.900	0.900	0.700	-
Dividend Growth	-33.33%	-33.33%	-	28.57%	-	-
Gross Margin	60.90%	61.24%	64.25%	67.36%	72.15%	72.40%
Operating Margin	8.12%	9.85%	14.17%	12.92%	13.60%	15.72%
Profit Margin	10.57%	11.63%	14.75%	14.14%	14.02%	15.26%
Free Cash Flow Margin	-12.16%	-6.49%	7.58%	1.84%	1.97%	5.36%
EBITDA	182.69	208.03	263.99	215.78	190.11	179.11
EBITDA Margin	13.27%	14.72%	18.43%	16.69%	16.58%	18.84%
D&A For EBITDA	70.88	68.9	61.02	48.79	34.22	29.67
EBIT	111.81	139.12	202.97	166.99	155.89	149.45
EBIT Margin	8.12%	9.85%	14.17%	12.92%	13.60%	15.72%
Effective Tax Rate	12.38%	14.17%	16.03%	11.06%	10.70%	11.83%
Revenue as Reported	1,376	1,413	1,433	1,293	1,147	950.63

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.